Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Perth Blood Institute (PBI) is a leading Australian non-profit research organization and clinical trial center specializing in hematological disorders. Based in Perth, Western Australia, the institute conducts extensive clinical research into venous thromboembolism, bleeding disorders, and various blood cancers, including myeloma and lymphoma. PBI operates as a high-capacity clinical trial site, partnering with global pharmaceutical companies to facilitate Phase I through IV trials. In addition to its research focus, the institute provides specialized patient care and educational programs aimed at improving outcomes for individuals with blood-related conditions. PBI is recognized as one of the largest independent hematology research facilities in Australia, bridging the gap between laboratory discovery and clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Perth Blood Institute.